We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Test Identifies Positive Tuberculosis Cases Within the Hour

By LabMedica International staff writers
Posted on 27 Sep 2010
A new test can identify positive tuberculosis (TB) cases within one hour, ensuring quick treatment for patients and reducing the incidence and consequences of TB worldwide.

Researchers at the Health Protection Agency (HPA; London, United Kingdom) developed a new ultra rapid test for the TB bacteria, Mycobacterium tuberculosis, which substantially increases the sensitivity of the test, enabling detection of the presence of the bacteria in a sample within an hour. More...
The new technique is a single DNA molecule identification test, which uses real-time polymerase chain reaction (PCR).

The new test focuses on a particular DNA region within the TB bacterium, which the researchers say is present in all strains of the disease. According to the researchers, the test can pick up very small amount of bacteria, and appears to be as sensitive as the gold standard TB identification, a bacterial culture grown from mucus coughed up from the lungs. However, the standard test can take up to eight weeks to reach a diagnosis, by which time the individual might have infected many more people. The study findings were presented at the HPA's annual conference, held during September 2010 at the University of Warwick (United Kingdom).

"We're excited to have developed this new test because it means we can potentially diagnose someone at a TB clinic within an hour and start them immediately on the treatment they need,” said study author Catherine Arnold, Ph.D., head of the HPA's genomic services unit. "This new test could really have an impact where it is most needed.”

TB is a common and often deadly infectious disease that usually attacks the lungs, but can also affect other parts of the body. Most infections in humans result in an asymptomatic, latent infection, but about one in ten latent infections eventually progresses to active disease which, if left untreated, kills more than 50% of its victims. The World Health Organization (WHO, Geneva, Switzerland) has estimated that one third of the world's population carries TB bacteria, and recent years have seen resurgence in TB infections in developed countries, as well as the rise of strains resistant to medication.

Related Links:

Health Protection Agency
University of Warwick
World Health Organization


New
Gold Member
Hematology Analyzer
Medonic M32B
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Laboratory Software
ArtelWare
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.